Leon Farber
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Leon Farber.
Powder Technology | 2003
Leon Farber; Gabriel I. Tardos; James N. Michaels
Abstract X-ray computed tomography (XRCT) is a technique that uses X-ray images to reconstruct the internal microstructure of objects. Known as a CAT scan in medicine, it has found wide application for whole-body and partial-body imaging of hard tissues (e.g., bone). A modern tabletop XRCT system with a resolution of about 4 μm was used to characterize some pharmaceutical granules. Total porosity, pore size distribution, and geometric structure of pores in granules produced using different conditions and materials were studied. The results were compared to data obtained from mercury porosimetry. It was found that while XRCT is less precise in the determination of total porosity in comparison to mercury porosimetry, it provides detailed morphological information such as pore shape, spatial distribution, and connectivity. The method is nondestructive and accurate down to the resolution of the instrument. Tomographic images show that the pore network of individual granules comprises relatively large cavities connected by narrow pore necks. The major structural difference between granules produced at different conditions of compaction and shear is a reduction in the pore neck diameter; the cavity size is relatively insensitive to these conditions. Comparison of pore size distributions determined from tomographic images and mercury porosimetry indicates that mercury intrusion measures the pore neck size distribution, while tomography measures the true size distribution of pores ca. 4 μm or larger (the instrument resolution).
Pharmaceutical Research | 2003
Huaiqiu Galen Shi; Leon Farber; James N. Michaels; Allison Dickey; Karen C. Thompson; Suhas D. Shelukar; Patricia N. Hurter; Scott D. Reynolds; Michael J. Kaufman
AbstractPurpose. The purpose of this work was to image crystalline drug nanoparticles from a liquid dispersion and in a solid dosage form for the determination of size, shape, and distribution. Methods. Crystalline drug nanoparticles were adsorbed from a colloidal dispersion on glass for atomic force microscopy (AFM) imaging. Nanoparticles that were spray coated onto a host bead were exposed by ultramicrotomy for scanning electron microscopy and AFM examination. Results. The adsorbed drug nanoparticles were measured by AFM to have a mean diameter of 95 nm and an average aspect ratio of 1.3. Nanoparticles observed in the solid dosage form had a size and shape similar to drug nanoparticles in the dispersion. Particle size distribution from AFM measurement agreed well with data from field emission scanning electron microscopy, static light scattering, and X-ray powder diffraction. Conclusions. AFM is demonstrated to be a valuable tool in visualization and quantification of drug nanoparticle crystals in formulations. In addition to accurate size measurement, AFM readily provides shape and structural information of nanoparticles, which cannot be obtained by light scattering. Ultramicrotomy is a good sample preparation method to expose the interior of solid dosage forms with minimal structural alteration for microscopic examination.
Handbook of Powder Technology | 2007
Gabriel I. Tardos; Leon Farber; D. Bika; James N. Michaels
Publisher Summary Granulation is used extensively in the pharmaceutical industry to produce larger granules from fine powdery particles to improve flowability and appearance, reduce dustiness, and to ensure thorough mixing of different ingredients. This last application is a very important unit operation in the pharmaceutical industry to produce non-segregating mixtures of dry powders that would otherwise strongly segregate because of differences in size, shape, density, and surface properties. The so-called “wet” granulation process uses liquids that are dripped, sprayed, or poured into a shearing mass of powder. The granulating fluid is typically composed of water and/or alcohol and may contain surfactants and polymeric binders such as hydroxypropyl cellulose (HPC) or polyvinylpyrrolidone (PVP). The process by which large dry granules are formed from fine powders by using liquid binders is quite complex. An accepted view holds that the liquid solution wets and spreads in the interstices among primary particles, forming liquid bridges that hold them together by capillary and viscous forces. These wet or “green” granules are subsequently dried and the liquid evaporated from the bridges to leave behind solid bridges or “necks” that impart mechanical strength to the dry granule.
International Journal of Pharmaceutics | 2007
Pavol Rajniak; C. Mancinelli; R.T. Chern; Frantisek Stepanek; Leon Farber; B.T. Hill
Powder Technology | 2005
D. Bika; Gabriel I. Tardos; S. Panmai; Leon Farber; James N. Michaels
International Journal of Pharmaceutics | 2008
Leon Farber; Karen Hapgood; James N. Michaels; Xi-Young Fu; Robert Meyer; Mary-Ann Johnson
Powder Technology | 2009
Karen Hapgood; Leon Farber; James N. Michaels
Chemical Engineering Science | 2003
Leon Farber; Gabriel I. Tardos; James N. Michaels
Powder Technology | 2009
James N. Michaels; Leon Farber; Gordon Wong; Karen Hapgood; Stephen J. Heidel; Julianne Farabaugh; Jun-Hong Chou; Gabriel I. Tardos
International Journal of Pharmaceutics | 2013
Lixia Cai; Leon Farber; Dina Zhang; Julianne Farabaugh